Home - Blank Rome LLP

Register to receive insights and analyses on breaking news and trends across varying industries.
<a class="link-primary mt-4" href="/subscribe">Subscribe</a>

Philadelphia, PA

New York, NY

Wilmington, DE

Cincinnati, OH

Princeton, NJ

Los Angeles, CA

Houston, TX

Tampa, FL

Shanghai

South Florida

Pittsburgh, PA

Washington, D.C.

Chicago, IL

Orange County, CA

Dallas, TX

Boston, MA

core/heading

Blank Rome partner <a href="/people/erica-r-graves/" id="18948">Erica R. Graves</a> will serve as a speaker at Food &amp; Drug Law Institute's <a href="https://www.fdli.org/2025/12/2025-enforcement-litigation-and-compliance-conference-for-the-drug-device-food-and-tobacco-industries/">Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco Industries</a>, being held December 4 through 5, 2025, in Washington, D.C., and virtually.

core/paragraph

This annual event brings together industry regulators, attorneys, litigators, academics, consultants, and other stakeholders to discuss trends and issues in enforcement and compliance. Hear from and interact with top officials from FDA, DOJ, FTC, and other government agencies, and gain valuable insights into the latest developments in both civil and criminal litigation, and recent cases and settlements.

Erica's session, "State-Level Challenges and Initiatives Amid FDA Enforcement Discretion," will take place on Friday, December 5, from 10:20 a.m. to 11:20 a.m.

This session explores the impact of state-level initiatives that arise when FDA exercises enforcement discretion. Topics include recent state laws on PFAS in packaging, Extended Producer Responsibility (EPR) and composability labeling mandates, and expanded state enforcement on greenwashing, ingredient disclosures, and nicotine sales—including proposed vape bans and retail restrictions. The discussion will also address key Section 310(a) preemption rulings on state efforts to enforce FDCA provisions via consumer protection or false advertising laws.

core/list-item

Meaghan Hembree, Partner, Holland &amp; Knight LLP

Samuel D. Jockel, Partner, Alston &amp; Bird LLP

Tony Subketkaew, Assistant General Counsel, General Mills, Inc.

core/list

FDLI Welcome and New Rules, New Risks: Inside the Changing World of Federal Inspections

Beyond the Rule: What to Watch in FDA’s QMSR Transition

Custom Meds, Custom Risks: Compounding Litigation and Enforcement

Enforcement on Trial: Recent Court Decisions Impacting FDA’s Authority

For more information and to register, please visit the&nbsp;<a href="https://www.fdli.org/2025/12/2025-enforcement-litigation-and-compliance-conference-for-the-drug-device-food-and-tobacco-industries/">event webpage</a>.

State-Level Challenges and Initiatives Amid FDA Enforcement Discretion

Offices

Stay Connected

Slide Menu

Slide Search

State-Level Challenges and Initiatives Amid FDA Enforcement Discretion

Offices

Stay Connected